Premium
Screening for bone health in epilepsy
Author(s) -
Sheth Raj D.,
Harden Cynthia L.
Publication year - 2007
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/j.1528-1167.2007.01401.x
Subject(s) - epilepsy , medicine , bone health , densitometry , bone mass , bone remodeling , bone mineral , disease , bone disease , dual energy , antiepileptic drug , pediatrics , physical therapy , osteoporosis , psychiatry
Summary Elderly and young patients with epilepsy are at risk for fractures from seizure and antiepileptic drug (AED) related falls and from epilepsy and AED related lowered bone mass. Enzyme inducing AEDs are often implicated, although, nonenzyme inducing medications may also impact epilepsy bone disease. Screening for bone health with direct measures, such as bone densitometry by dual‐energy x‐ray absorptiometry (DEXA) and indirectly via biochemical markers of bone turnover may help identify patients who are at increased risk for fractures and offer an opportunity for intervention.